Videonystagmography and Vestibular Migraine
Launched by DR. MED. LUKAS BECKER · May 22, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how effective a specific test called videonystagmography (VNG) is in diagnosing vestibular migraine compared to other types of migraines and healthy individuals. VNG is a test that helps doctors understand balance problems and vertigo (a sensation of spinning). The researchers want to find out if there are noticeable differences in test results among patients with vestibular migraine, those with other types of migraines, and people without any migraine issues.
To join the study, participants need to fall into one of three groups: those with a confirmed diagnosis of vestibular migraine, those with episodic or chronic migraines (but not vestibular migraine), or healthy individuals without any type of migraine. People with certain conditions, such as other vertigo disorders, hearing loss, and some chronic diseases affecting balance, will not be eligible. If you join the study, you can expect to undergo the videonystagmography test, which is non-invasive and designed to help improve the understanding and diagnosis of vestibular migraine. This could lead to better treatment options for those who suffer from this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Group 1: The diagnosis of vestibular migraine is confirmed.
- • Group 2: The diagnosis of episodic or chronic migraine is confirmed. There is no coexisting vestibular migraine.
- • Group 3: healthy subjects without vestibular migraine and episodic or chronic migraine
- Exclusion Criteria:
- • Simultaneous presence of another confirmed vertigo disorder
- • A previous hearing loss
- • Simultaneous presence of a chronic disease that affects the sense of balance
- • Taking medication with a central effect that affects the sense of balance
- • An existing eardrum defect or a blocked ear canal due to earwax
About Dr. Med. Lukas Becker
Dr. med. Lukas Becker is a distinguished clinical trial sponsor dedicated to advancing medical research and improving patient care through innovative clinical studies. With a robust background in medicine and a commitment to ethical research practices, Dr. Becker oversees a diverse portfolio of trials that explore cutting-edge therapies and treatment modalities. His organization prioritizes patient safety, rigorous scientific methodology, and collaboration with leading healthcare professionals to ensure the successful execution of clinical trials that contribute valuable insights to the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Essen, Nordrhein Westfalen, Germany
Patients applied
Trial Officials
Dagny Holle-Lee, Prof. Dr. med.
Study Director
Klinik für Neurologie, Universitätsklinikum Essen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported